SS
Sreechith Sundaresan
About Sreechith Sundaresan
Data last updated:
Sreechith Sundaresan is a Managing Director at Spress Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Spress Pharmaceuticals Private Limited U47721KL2024PTC088587 | Managing Director | 10 Jul 2024 | 2024 | Active |
Board colleagues of Sreechith Sundaresan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pranoop Gopalankutty | 10702048 | Spress Pharmaceuticals Private Limited | Director |
| Sarath Kalathil Sivadasan | 10702049 | Spress Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sreechith Sundaresan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sreechith Sundaresan
Sreechith Sundaresan currently holds 1 directorship: Spress Pharmaceuticals Private Limited (Managing Director, since 10 Jul 2024).
Sreechith Sundaresan was first appointed on 10 Jul 2024 as Managing Director at Spress Pharmaceuticals Private Limited.
The current boards of Sreechith Sundaresan's companies include Pranoop Gopalankutty (Spress Pharmaceuticals Private Limited), Sarath Kalathil Sivadasan (Spress Pharmaceuticals Private Limited).